PharmaResearch expands Rejuran global market presence in Hungary and Saudi Arabia

PharmaResearch is expanding its global footprint for its polynucleotide (PN)-based skin booster, Rejuran, through recent launches in Hungary and Saudi Arabia.

In Hungary, the company held an official launch symposium in Budapest to introduce three Rejuran products: the standard Rejuran, Rejuran I for thin skin such as the eye area, and Rejuran S for wrinkles and scars. The event featured medical experts from Korea, the Czech Republic, Slovakia, and Hungary, who shared clinical applications and regeneration principles. PharmaResearch plans to utilize local partner networks to expand into major Hungarian cities and neighboring European markets.

Simultaneously, PharmaResearch conducted launch symposia in Riyadh and Jeddah, Saudi Arabia, targeting the Middle East's growing medical aesthetics market. Following medical device approval in early 2024, the company is working with local partners to increase brand awareness among dermatologists and plastic surgeons. The company aims to use Saudi Arabia as a strategic hub to expand its presence across the Gulf Cooperation Council (GCC) and the broader Middle East and North Africa (MENA) region.